Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PSNL | Common Stock | Exercise of in-the-money or at-the-money derivative security | $6.91M | +4.61M | $1.50 | 4.61M | Aug 16, 2024 | Direct | ||
transaction | PSNL | Common Stock | Exercise of in-the-money or at-the-money derivative security | $11.5M | +4.61M | +100% | $2.50 | 9.22M | Aug 16, 2024 | Direct | |
transaction | PSNL | Common Stock | Purchase | $17.7M | +3.5M | +37.97% | $5.07 | 12.7M | Aug 16, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PSNL | Warrant (Right to Buy) | Exercise of in-the-money or at-the-money derivative security | -4.61M | -100% | 0 | Aug 16, 2024 | Common Stock | 4.61M | $1.50 | Direct | F1 | ||
transaction | PSNL | Warrant (Right to Buy) | Exercise of in-the-money or at-the-money derivative security | -4.61M | -100% | 0 | Aug 16, 2024 | Common Stock | 4.61M | $2.50 | Direct | F1 |
Id | Content |
---|---|
F1 | The Reporting Person acquired the warrants as partial consideration for its obligations to the Issuer under that certain Commercialization and Reference Laboratory Agreement, dated November 25, 2023, between the Issuer and the Reporting Person. |